Physiological Role
Vitamin B12 (cobalamin) acts as a cofactor for two essential enzymes. Methionine synthase converts homocysteine into methionine, an amino acid needed to produce S-adenosylmethionine (SAM). SAM is the body's primary methyl group donor. It participates in gene expression regulation, neurotransmitter synthesis and myelin maintenance, the protective sheath around nerve fibres.
The second enzyme, methylmalonyl-CoA mutase, participates in the metabolism of odd-chain fatty acids and certain branched-chain amino acids. Insufficient B12 intake leads to methylmalonic acid (MMA) accumulation, a functional indicator used in clinical biology.
B12 also contributes to normal red blood cell formation. When increased needs are unmet, cell division of erythrocyte precursors slows down. This results in larger-than-normal red blood cells (macrocytosis). This phenomenon is shared with vitamin B9, as both vitamins are interdependent within the methylation cycle.
Reference Ranges
These reference ranges are derived from scientific literature and may differ from your laboratory's reference values.
Biological Significance
A vitamin B12 level in the optimal zone reflects a functional methylation cycle and adequate tissue reserves. This is associated with balanced homocysteine metabolism and normal red blood cell production.
Values in the low zone warrant particular attention. B12 absorption naturally decreases with age due to reduced gastric acidity and intrinsic factor. Vegetarian or vegan diets represent another common factor for suboptimal values. Chronically low levels may be reflected in other Singular panel markers, notably homocysteine or mean corpuscular volume.
Elevated values typically reflect active supplementation. Longitudinal tracking distinguishes supplementation-related elevation from variation requiring complementary attention.
Cross-reading vitamin B12 alongside homocysteine, vitamin B9 and mean corpuscular volume provides a systemic view of the methylation cycle. This integrated approach is central to the Singular methodology.
Influencing Factors
Diet. Vitamin B12 is found exclusively in animal products and certain fermented foods. Vegan diets do not cover B12 needs without supplementation. Vegetarian diets may provide adequate intake through eggs and dairy, but reserves warrant regular monitoring.
Age. Intestinal B12 absorption decreases progressively with age. Hydrochloric acid and intrinsic factor production, essential for B12 release and absorption, naturally decline after age 50. This decline can be amplified by chronic proton pump inhibitor use.
Medications. Proton pump inhibitors (PPIs) and metformin are the two drug classes most frequently associated with decreased B12 status. PPIs reduce the gastric acidity needed to release dietary B12. Metformin interferes with ileal absorption.
Gut health. Ileal mucosal integrity determines B12 absorption. Malabsorption conditions can compromise B12 status independently of dietary intake.
Genetics. Certain polymorphisms affect B12 transport proteins (transcobalamin, haptocorrin). These variations can influence tissue bioavailability, even when blood levels appear normal.
Supplementation. The Singular formula contains vitamin B12 as methylcobalamin. Vitamin B9 and vitamin B6 (P5P), also present in the formula, are interdependent cofactors in the methylation cycle. Trimethylglycine completes this network as an alternative methyl donor.
In the Singular Formula
Vitamin B12 is part of the biomarker panel measured by Singular to map individual nutritional status. Its role in the formulation engine is contextual. It provides insight into the body's methylation capacity without triggering specific dosage adjustments.
The Singular formula includes vitamin B12 as methylcobalamin. This coenzyme form requires no hepatic conversion to become active. It participates directly in the methionine cycle and homocysteine metabolism. Methylcobalamin is combined in the formula with vitamin B9 as 5-MTHF (methylfolate) and vitamin B6 as P5P (pyridoxal-5-phosphate). This trio forms the cofactor foundation of the methylation cycle.
Trimethylglycine (TMG), a methyl group donor via the betaine-homocysteine methyltransferase pathway, completes this network. It offers an alternative homocysteine recycling route. Iron as bisglycinate, also present in the formula, works synergistically with B12 in normal red blood cell formation.
The Singular panel simultaneously measures vitamin B12, homocysteine, vitamin B9 and mean corpuscular volume. This cross-reading evaluates the methylation cycle's overall efficiency.
Linked Bioactives
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Green R et al. | 2017 | Systematic Review | Nature Reviews Disease Primers | View on PubMed |
Vitamin B12 deficiency Comprehensive review covering the epidemiology, pathophysiology and management of vitamin B12 status. The authors highlight the importance of regular monitoring in at-risk populations, particularly older adults and vegans. | ||||
| Smith AD et al. | 2010 | Randomised Controlled Trial | PLoS ONE | View on PubMed |
Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial Randomised controlled trial (VITACOG) showing that B vitamin supplementation (B9, B12, B6) reduces the rate of brain atrophy by 30% in subjects with mild cognitive impairment, and up to 53% in those with elevated homocysteine. | ||||
| Douaud G et al. | 2013 | Randomised Controlled Trial | Proceedings of the National Academy of Sciences | View on PubMed |
Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment VITACOG trial extension showing that B vitamin supplementation protects the most vulnerable brain regions. The protective effect depends on initial homocysteine levels. | ||||
| Hunt A et al. | 2014 | Systematic Review | BMJ | View on PubMed |
Vitamin B12 deficiency Clinical review synthesising absorption mechanisms, causes of suboptimal values and monitoring approaches. The authors emphasise progressive age-related absorption decline and the impact of proton pump inhibitors. | ||||
| Stabler SP | 2013 | Systematic Review | New England Journal of Medicine | View on PubMed |
Clinical practice. Vitamin B12 deficiency Reference article detailing neurological and haematological manifestations associated with suboptimal B12 status. The author highlights methylmalonic acid as a complementary functional indicator. | ||||
| Clarke R et al. | 2007 | Cohort Study | American Journal of Clinical Nutrition | View on PubMed |
Low vitamin B-12 status and risk of cognitive decline in older adults 10-year prospective cohort study establishing an association between low vitamin B12 status and accelerated cognitive decline in adults over 65. | ||||
| Andrès E et al. | 2004 | Systematic Review | Canadian Medical Association Journal | View on PubMed |
Vitamin B12 (cobalamin) deficiency in elderly patients Clinical review focused on older adults, demonstrating that the prevalence of low B12 values increases significantly after age 60. The authors recommend regular monitoring in this population. | ||||